drugset / Trial / NCT07435077

Examining Analgesic Synergy and Efficacy in Trauma Care

NCT07435077

Phase 4 Not yet recruiting 282 enrolled Wake Forest University Health Sciences
RandomizedParallel-groupSingle-blindTreatment

Summary

Traumatic injury is responsible for over 25 million (16%) Emergency Department visits and over 225,000 deaths each year per 2021 Center for Disease Control data. This is the 3rd leading cause of death in the US. Often, acute care for the injured patient requires administration of pain medication for the purposes of acute pain control from injury. The mainstay of treatment for pain control has historically involved opioid pain medication.

Timeline

Start
2026-08
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 2 mg Intravenous
Subject Oxycodone Other / unclassified